Member Info for LoneSurvivor

I don't know whether to be happy or not that we go a month between posts sometimes on this forum. I understand that the volume of share trading in SiS is small because this company has only a small proportion of general shareholders. The majority of shares sits with institutions, HNW individuals or investment houses but with each piece of more promising commercial news that is released by SiS in the coming 12 months there will be a scramble to buy the few shares that are freely traded. That will nudge up the price. We see a block of 50,000 or 100,000 traded every now and again and that is a drop in the ocean. Of course the downside is that when an eventual deal (an acquisition) comes knocking in 2027? or thereabouts, the general shareholders will not really be able to have a say it whether it happens or not. That will be decided by those with more skin in the game. Patience is a virtue they say

Sb88 - Sorry, don't hate me. I am just trying to look at the facts from the previous trials and I don't take any pleasure from my 'crystal balls' calling this one correctly. I didn't understand the comment of one poster who basically said that if you're not currently invested here then you shouldn't post. They are essentially saying that only those with a positive view of this company should post here and no dissenting voices should be heard. My point was that a debate on the pros and cons of a company/share is surely what helps us make decisions. I was previously invested until the main trial results were released and I lost some money too. My perspective now is that Eroxon will probably be a niche product that works for some but not enough to take on the little blue pill. The original concept, with the drug GTN contained in the gel made a lot of sense but for some reason it didn't work. I believe it should work, if delivered correctly and at the correct dose, and so rather than develop the gel without GTN in it I would have gone back to understand the delivery more. That takes a lot of money. So let us hope this share gains traction and that if it works for some it will generate good revenue on which to build again.

Well I did try to warn some of you....rpg7, Hope1968, Arturodeldia. I set out my logic and experience of drug trials and states that the placebo effect was not going to create a blockbuster. For my troubles I was attacked and called a 'dreary deramper'. I've been called worse ! Even Sushi is back in desperation today. Why do people always jump on those who try to present genuine evaluation. Not everybody is trying to push a share up or down and these sites are really not going to effect a share price. A wise old CEO that I worked for in the 1990's said 'under-promise and over deliver'. It seems as though FUM's CEO has got that message the wrong way around. Repeat sales will struggle but there will be a place for this in the market and the share price has re-trenched until the level of repeat sales is clear in the US. Don't expect a recovery anytime soon but feel free to bash me again. I am a dreary deramper after all.

Well what do people think of the signs of growth returning to the business? The departure of old sushi-loving Mr Moon reveals what I always believed i.e. that his blind and incompetent chase for revenue, at all costs, while milking the business through his salary and share options was holding this company back. The tide has now turned but as I previously noted we need a couple of full years to make this business look attractive for an acquisition. The loss of revenue by exiting some of the old CEO's unprofitable follies has not resulted in a collapse in sales (-17.5%) and what we do have is profitable. By the start of 2026 we will have an embedded growth trajectory and this 15% EBITDA target in sights. Will we be selling shares at 70-90p again at some stage. I firmly believe that is possible.

Just for clarity. The original product contained glyceryl tri-nitrate (GTN) which dilates blood vessels. That is how it was supposed to work. In the large trial one in four people (23%) found it worked for them (wonderful) but one in seven people found the placebo gel worked with absolutely no GTN in it. Just a cold evaporating gel applied to the little fella.

So after that disappointment FUM decided to develop the placebo with nothing active in it as a "medical device" and not a drug. If it works for some people that's wonderful but lets see where the share price goes. I am accused of "de-ramping" but I have no interest in buying these shares, I just wanted to stop a certain individual from posting 2-3 times a day saying "strong buy, strong buy" . He (or she) has done it to other shares. I believed in the original products possibilities and that is why I previously invested. I wont be repeating the mistake

He certainly has rpg7. But its going the be the best asylum ever and people (important people) have told him so. He's going to put tariffs on his fellow inmates and all will be well. I think I'll give up here, and just suggest to new investors to go look at the efficacy data for EROXON. My view is that there is no evidence that it works at all. Some people will have a psychological response but my guess is that this will not be repeated and therefore repeat sales will skydive. The little blue pill may have its limitations but its mode of action is real. This is all in the head of the sufferer.

@Hope1968. Believe me I am not trying to devalue this stock. I held (past tense) FUM stock some time ago and took a fairly big loss when the original clinical trials failed. Yes failed ! I am sorry but this is not going to be a blockbuster. @Discoman1 we humans do indeed buy an expensive product when there is a cheaper alternative available but I imagine when it comes to 'rousing the dead' people will want something that is actually effective. By all means have a punt on this stock but please don't lose your shirts on it, or lose sight of the fact that this product was actually the placebo gel in a failed clinical trial.

Really Sushi, aka Mr Moony. Its a placebo! Just ask your mate John on the FUM Board...... but no insider trading of course. A cold evaporating gel that has no bioactive ingredient. It might fool users once, with a purely psychological effect but repeat orders (if there were any) would show it actually works. I fear there are not going to be many of those. 60p - I nearly fell off my bike (oops sorry touchy subject). This share will struggle to maintain a firm price and drift once the US repeat sales figures roll through.

All quiet on the news front? A ship now steadied but the occasional spate of significant share trades interspersed by quiet spells. Are these deals existing shareholders lessening their stake somewhat stealthily over time or others maneuvering for control ahead of a future deal? A few big players hold meaningful positions. Meanwhile the former CEO's website and musings on his own fragilities shows such lack of self-awareness. The impact he had on some colleagues here and in past positions is lost in the self-pitying attempts at understanding. They say 'physician heal thyself' but how about undoing all the damage you did and leaving a clean slate. That's all that matters Mr Moon when the final reckoning comes and when SiS lifts off we will know who really contributed and who just clambered over the bodies to get what they wanted. Can wait for the next set of SiS figures.

No sushi for a month ! Maybe there really is no smoke without fire and he was SM ! He's certainly active elsewhere trying to chase up share prices like FUM. Unfortunately for him FUM's product isn't 'stiffening' up anything with reliable regularity and so nobody knocks twice. Anyway enough puns for now......, todays half year results for SIS reveal the extent of the reset. Half year revenue is hit (perhaps much less than I feared) and early shoots are visible of increased profitability, which we hope they will grow further (as per their promise), after exiting unprofitable channels. Can anybody remember what was the share price was previously when revenue was about £50M annually?? A little higher than 25p ?? The next 6 months are critical for the Board to prove their strategy and although the journey will take a couple of years I feel we may now be on the right path to a business worth selling at a premium.

And I though it was Henry, the mild mannered janitor. So perhaps Sushi's hidden identity is revealed, but in reality I think SM was far too much of a narcissist to care about an online discussion forum. He was/is ruthless in his management style but shrewd enough to know such forums couldn't affect the SiS share price and anyway he was too busy blogging elsewhere to his follower(s). The new management "values its retail investors" we are told so we can expect a different approach. The online investor meetings were as painful as the company meetings you clearly sat through Mr Foreverhopeful. I have held these shares for 12 years so I think I too must be forever hopeful or maybe just deluded !

Well Laura2022, our raw fish and rice loving friend certainly stands accused of some ramping up in the short term but his optimism isn't completely deluded, if viewed slightly more long-term. The Exec Chairman just put £1M in to this business at 17p. He clearly thinks they can get substantial traction in next 2-3 years and wants a piece of that action, when this business is sold (which it will be eventually). As I said in my earlier note I wasn't happy to put more money into the retail placing to prevent my own dilution, and I wouldn't have done it at all if Stephen Moon were still there 'bending over' the shareholders every couple of years. This does feel different and even the incentive plan announced yesterday is weighted to growth in market capitalisation and not revenue (the previous CEO really did bend the shareholders over each time he did a placing). There would have been no placing offer to smaller shareholders previously as Mr Moon was only driving his own interests. So I do feel that, as much as Sushi is not helping others believe in the potential. It is possible to see 50-60p in 3 years time. Watch this space !

Oh and Sushi, I received my corporate action this morning with a 2pm deadline on the retail placing offer. I have committed a fair amount more cash to maintain my holding (not something I do comfortably or willingly) but I do feel that this company will make a profit in a few years and I wont let the new management dilute my share of the business that I have fought to maintain for 12+ years ! I was here before them.

I think what our Japanese food loving shareholder doesn't address is that liquidity in this stock is so limited. The vast majority of the shares are in large institutional investors hands and HNW individuals. The share price wont change on private investors confidence (or lack of it) in a placing and the "holding up" of the share price is simply because the larger shareholders wont sell at this price. I must say to Sushi that I hold more shares than a number of the Board (at least unti today !) so I want this to rise. However, we cannot affect this and its a placing that appears organised to help the management take a share of a future sale.

Where is "Sushi" indeed with his rampant (or should be ramping) promise of great days ahead ! What was it? 40p was looming Sushi ? Sadly deluded. This 25% dilution and its manner is very unwelcome. We thought that the new management was taking a different approach to Mr Moon but here we go again. I was there at the start when SiS entered AIM through the reverse takeover of Provexis. 56p a share at launch and 12-13 years later we are where we here at 17p. They don't even seem to have a great reason for the £8m needed. The Directors will put in £1M so I guess they believe the true value is higher than 17p but what a sorry story this has been.

Lets take a level headed look at this and not use tabloid headlines shall we. So much of this stock is in the hands of large institutional investors and private individuals. You will not affect the share price with such inflammatory summaries whether ramping the share or kicking it. If a business gives up 25% of its sales because they are not profitable that is going to hurt in the short term. It is a brave and sensible decision to reset this business in a market we know is growing long term. We now know that revenues for full year 2024 will be down and profit signals will grow. Two years from now this business will be in a strong position if it doesn't get bought out in the interim. We private investors wont influence that but those institutional investors with a significant holding know the share price will rise and they are not selling at this price. The plan is clear and so now lets see of these new hires know what they are doing.

Well the trading update shows the contempt for the one trick pony 'revenue' chasing of the previous CEO and top management (actually lets be honest just the CEO) and this was an honest if somewhat mixed bag of an announcement. I like honesty ! We will have to wait while they de-leverage and rebuild and so 2024 will be flat on revenue but with improved EBITDA, reduced debt and an expectation that they can double the cash position. I saw no obvious signal for a further fund raise or dilution of investors (although cannot rule one out at some future stage). The strategy they intend to follow doesnt necessarily need a big cash injection just a bot of time. The goals are clearly stated for us to see in this trading update. Patience is needed but I sense we are in better hands and we know how we will measure success in 12 and 24 months. I read this with a sense of optimism going forwards.

Interesting to have exchange of views. I think the ex-CEO is on garden leave simply because they wanted to remove him quickly from his influence on the business. He is not the sort of guy you want wandering around the office after 'agreeing' his departure, and his contract has always had 12 months notice period. Paying him off in one go or not is a choice. One thing Mr Moon was right on (yes there were just one or two things) was that retail is not the future and I would be very surprised if they turn the ship in that direction. Your comment on not paying suppliers is powerful, if that turns out to be true, but I have serious doubts that is true. They are not that tight on cashflow and there is an underlying profitability margin that I believe can be unlocked now that he is gone. The next trading statement will be interesting and perhaps we can pick this exchange up again once we have it.

At least there is balance now from one doom monger and one ramper in our midst. Let the team do their work. The previous Chairman and CEO held this business back and put the relentless push for revenue before anything else. The new leadership team will be able to deliver profitability but don't expect it overnight. A trading update will come in good time and the new team is at least aligned with (& representing) their major investors. Not just promising jam tomorrow, which is all Mr Moon did for a decade because he was devoid of any sense he owed his backers anything. Why do they need a fundraise and cash? The new facility is built, has future proof capacity and the remaining team is trimmed to deliver. I've waited 12 years on this investment and can wait another 1-2 years which should see the profitability moving in the right direction.

When a director (e.g. and ex CEO) leaves the company and does so under a Compromise Agreement, he will have a fixed period of time to exercise and/or sell his existing share options. Mr Moon is probably on a 12 month notice period of gardening leave but the window to move on his shares could be shorter. Therefore its logical to sell some at this stage. The "new blood" leadership isn't investing £110k just to double his money (or that of his family Trust). He is hoping for multiples of this return on his investment. Nothing is happening quickly so give them time. They need to re-position this business as profit making. Other big investors topping up (we we saw too here) is also a great thing to see. Whether or not we see 70p per share again is very uncertain but we are going to see a climb and I am looking forward to the pre-close figures next month.